LEUKODYSTROPHY, HYPOMYELINATING, 15
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy.
|
29576217 |
2018 |
LEUKODYSTROPHY, HYPOMYELINATING, 15
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Leukodystrophy, hypomyelinating
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy.
|
29576217 |
2018 |
Failure to Thrive
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
The clinical presentation of our patients differs from the original QARS-associated syndrome in the severe postnatal growth failure, absence of epilepsy, and minor MRI findings, thus further expanding the phenotypic spectrum of the glutaminyl-tRNA synthetase deficiency syndromes.
|
28620870 |
2017 |
Global developmental delay
|
0.110 |
Biomarker
|
disease |
BEFREE |
Glutaminyl-tRNA synthetase (QARS) deficiency has been described to be a cause of a neurodegenerative disorder associated with severe developmental delay, microcephaly, delayed myelination, and intractable epilepsy.
|
28056632 |
2017 |
Failure to Thrive
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Reticulocyte count (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Amblyopia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Athetosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Leukodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Optic Atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pyramidal sign
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Action Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Impaired cognition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Developmental regression
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|